Scientists have discovered a highly effective antibody with 4-6 months of protection against SARS-CoV-2

The newly identified antibody was isolated from the lymphocytes of COVID-19 patients who participated in the immunization coronavirus research conducted by CHUV's Immunization and Allergy Service Center

In addition to its antiviral properties, this new antibody is also designed to have a lasting effect on humans

Currently, CHUV and EPFL plan to cooperate with a start-up company to carry out clinical development and production of this antibody-containing drug through cooperation and intellectual property agreements

Treatment or prophylaxy

This research was conducted by CHUV's immunology and allergy services led by Professors Giuseppe Pantaleo and Craig Fenwick, and EPFL's Virology and Genetics Laboratory led by Professor Didier Trono and Dr.

The discovery of this new antibody marks an important step forward in the fight against COVID-19

references

Craig Fenwick, Priscilla Turelli, Laurent Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, Jérémy Campos, Erica Lana, Flurin Fiscalini, Charlène Raclot, Florence Pojer, Kelvin Lau, Davide Demurtas, Marc Descatoire, Victor S.

https://doi.

Magazine

Cell report

DOI

10.

Methodological research

Experimental Study

Subject of research

animal

Article title

A highly effective antibody against SARS-CoV-2 mutation

Article publication date

12-October-2021